A Non-interventional Study for the Collection of Biospecimens From Patients With Parkinson's Disease

NCT04893083 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2023-10-30

No results posted yet for this study

Summary

This study aims to collect, analyze and preserve biospecimens from patients with or without LRRK2-associated Parkinson's Disease for the purpose of discovering and developing new treatments and novel biomarkers.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • Neuron23 Inc.

    lead INDUSTRY

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-28
Primary Completion
2023-06-30
Completion
2023-09-22

Countries

  • United States
  • Canada
  • France
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04893083 on ClinicalTrials.gov